Jul 2 2014
In an era of increasing regulatory scrutiny and changing social environment there are increasing complex demands for compliance teams related to globalisation, information privacy and security, HCP interactions and external reporting requirements.
This ebook shares the thoughts of industry representatives on what they find the biggest challenges faced in their day to day work. They also give insight and thoughts on the implications to the industry and how the compliance role will change over the next 5 years.
Learn:
- What are the biggest challenges in compliance currently?
- How are greater transparency requirements in Europe affecting compliance?
- What are the specific risks for pharma with regards to bribery, corruption and trust? How do you minimise these risks?
- How do you see the compliance role changing in the next 5 years?
Participants include Ana Prada, EMEA Corporate Counsel, Ethics & Compliance, Baxter Healthcare, Martina Heidelberger, EMEA Compliance Manager, F.Hoffmann-La Roche LTD, Thierry Meulenbroek, Head of Medical Compliance, Abbvie, Jeffrey Gibbs, Vice President Internal Audit, Biogen Idec, Matthijs Blokland, Former Managing Director, Nefarma, Prof. Vincenzo Costigliola, President, European Medical Association, Paul Dixey, Managing Partner, Bluelight Partners, Paul Woods, Managing Director, Paul Woods Compliance, and Diva Duong, Vice President Compliance EMEA, Cegedim Relationship Management.
Download the ebook
Following on from the success of their inaugural Pharma Compliance conference, Health Network Communications are hosting Pharma Compliance 2014 in London this October 7-8th and would love to see you there.
The 2nd annual event will provide you with global regulatory updates and case studies from experts with practical experience of successfully optimising their company’s compliance strategies. Learn compliance best-practice with advice on anti-bribery and trust initiatives, marketing and communication strategies, transparent reporting and more.
For more information, click here